Löfgren Mats, Poromaa Inger Sundström, Stjerndahl Jan Henrik, Renström Birgitta
Department of Clinical Science, Obstetrics and Gynecology, Umeå University Hospital, Umeå, Sweden.
Acta Obstet Gynecol Scand. 2004 Dec;83(12):1202-7. doi: 10.1111/j.0001-6349.2004.00609.x.
The purpose of the study was to evaluate the current use of antibiotic prophylaxis, the rate of postoperative infections, and risk factors for postoperative infections in patients undergoing elective hysterectomy for non-malignant pathology.
The study was performed during the time period July 2000 to 1 January 1 2003, using data from the Swedish National Register for Gynecologic Surgery, covering 26 of 49 clinics and approximately 50% of the Swedish population. During this time period, 3267 women undergoing elective hysterectomy for non-malignant pathology (mainly dysfunctional bleeding and fibromas) and with complete data on the use of antibiotic prophylaxis and postoperative follow up were included. A postoperative infection was considered to have developed if patients or the physician reported an infection related to the surgical site, together with reported use of antibiotic treatment.
Among the 3267 patients, 341 (10.4%) were considered to have developed a postoperative infection. In cases where antibiotic prophylaxis had not been given, total abdominal hysterectomies and vaginal hysterectomies were associated with the highest frequency for postoperative infections P < 0.05 and P < 0.01, respectively. Notably, also women undergoing subtotal hysterectomy reported significantly lower rates of postoperative infections if prophylactic antibiotics had been given, P < 0.05. Risk factors for postoperative infection were non-use of antibiotic prophylaxis, hospital, age less than 40 years, and BMI > 30 kg/m(2).
The study results have indicated the need of prospective clinical trials on antibiotic prophylaxis for patients undergoing supravaginal abdominal hysterectomy. Also, a need to further evaluate the current prophylactic antibiotic protocols used for obese patients and younger women undergoing any kind of hysterectomy is warranted.
本研究旨在评估非恶性病变择期子宫切除术患者抗生素预防性用药的当前使用情况、术后感染率及术后感染的危险因素。
本研究于2000年7月至2003年1月1日期间进行,使用瑞典国家妇科手术登记处的数据,涵盖49家诊所中的26家以及约50%的瑞典人口。在此期间,纳入了3267例因非恶性病变(主要为功能失调性子宫出血和纤维瘤)接受择期子宫切除术且有抗生素预防性用药及术后随访完整数据的女性。如果患者或医生报告与手术部位相关的感染,并报告使用了抗生素治疗,则认为发生了术后感染。
在3267例患者中,341例(10.4%)被认为发生了术后感染。在未给予抗生素预防性用药的情况下,经腹全子宫切除术和经阴道子宫切除术的术后感染发生率最高,分别为P < 0.05和P < 0.01。值得注意的是,接受次全子宫切除术的女性如果给予预防性抗生素,术后感染率也显著降低,P < 0.05。术后感染的危险因素包括未使用抗生素预防性用药、医院、年龄小于40岁以及BMI > 30 kg/m²。
研究结果表明,对于经阴道上腹部子宫切除术患者,需要进行抗生素预防性用药的前瞻性临床试验。此外,有必要进一步评估目前用于肥胖患者和接受任何类型子宫切除术的年轻女性的预防性抗生素方案。